Our Current Tenants
BioBAT’s tenants are part of a growing ecosystem of cutting edge research and talent in Brooklyn.
Learn more about the companies making up BioBAT’s community.
AlgiKnit
AlgiKnit Inc., now known as Keel Labs, is a biomaterials company integrating science and design into textile production. Addressing the ecological damage caused by the fashion industry, AlgiKnit is creating durable yet rapidly degradable yarns. We are proud to have helped Keel Labs grow, as their operations have moved to New Jersey.
Biotia
Biotia is a health tech company, launched from Cornell Tech and Weill Cornell Medicine, that leverages DNA sequencing-based technology and proprietary AI-powered software to rapidly and accurately identify microorganisms and antimicrobial resistance. Their mission is to fight infectious disease by deploying the leading reference library of microbes worldwide.
Calder Biosciences
Calder is a private biotechnology company applying proprietary technologies to develop conformationally locked, improved subunit vaccine immunogens. The company’s technologies enhance the performance of these products by stabilizing their conformations, which then better represent the 3-D structure of these proteins on the surface of the pathogen, and therefore give rise to more protective antibody responses. Calder is collaborating with several organizations to develop products and technologies in this space, including the Vaccine Research Center/NIAID, the University of Texas (Austin), PATH, Vanderbilt , the University of Pittsburgh, the University of Miami.
Chemitope Glycopeptide
Chemitope Glycopeptide, LLC, or Chemitope, is a boutique biotech company that aims to produce a new generation of preventative vaccines. Chemitope was founded by Dr. Baptiste Aussedat and Dr. William Walkowicz, two PhD scientists at Memorial Sloan Kettering Cancer Center in New York City, to meet the current and future demand for homogeneous glycopeptides in the ongoing effort to develop an HIV vaccine.
Cortecnet
CortecNet distributes Nuclear Magnetic Resonance (NMR) consumables and stable isotope enriched compounds. We provide various consumables, including NMR tubes and NMR rotors. We also provide stable isotope enriched products, including deuterated solvents, uniformly and selectively labeled amino acids, uniformly and selectively labeled carbohydrates, isotopic gases, metal isotopes, deuterated lipids and labeled protein standards. In addition, CortecNet offers biological products, such as antibodies, elisa kits, and molecular biology from ADI; analytical products, including, NMR, EPR consumables, seringes and GC columns from SGE, UV-Visible / IR consumables, CHN,O,S;AAS;ICP/ICP-MS consumables.
Fork & Good
Fork & Good presents a delicious alternative to meeting our meat cravings. Offering delicious flavor, our product is made of real meat, delivering the same essential nutrition with no antibiotics, no hormones, no harmful bacteria, and reduction in harm to animals and the environment, while using only the highest quality natural ingredients. Fork & Goode is addressing high initial costs by using specific and unique innovations to grow cells without need for expensive serum input, increasing cell density using 3D cell growth so costs are spread over a much greater mass of meat, and starting with multiple cell types to achieve both the flavor and nutritional profile of real meat. We are proud to have helped Fork & Good grow, as their operations have moved to New Jersey.
International AIDS Vaccine Initiative
IAVI's Vaccine Design and Development Laboratory (DDL) is a versatile facility designed to create novel immunogens, develop viral vectors, evaluate potency and advance promising candidates to clinical evaluation. The DDL has also established common preclinical standards for the vaccine field. Their goals are to understand the basis of naturally evoked, broadly neutralizing antibodies against HIV and other Emerging Infectious Diseases (EID) such as, but not limited to, Lassa fever, Marburg virus, and Covid-19.
Regen Lab® USA LLC
RegenLab® is recognized as a certified global leader in medical biotechnologies, specializing in cellular therapies. RegenLab® is at the forefront of innovation, with an expertly designed medical device for the preparation of platelet rich plasma from the patient's own blood. Regen® A-PRP® was developed with a focus on product quality, patient safety, and preparation efficiency. Our patient-centered technology has led to over one million treatments provided worldwide using RegenLab® products. As we look to the future, we are committed to guiding new standards for emerging categories within the field of regenerative medicine.